Evidence map›Paper›PMID 27280068›Full record

ArticlePeerJ2016

Assessing Illumina technology for the high-throughput sequencing of bacteriophage genomes.

Branko Rihtman, Sean Meaden, Martha R J Clokie, Britt Koskella, Andrew D Millard

Abstract read
In one paragraph

Article in PeerJ, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Rolling outMicrobial genomics · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Characterization and application of a novelCurrent research in food science · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Phage Genome Annotation: Where to Begin and End.PHAGE (New Rochelle, N.Y.) · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Branko RihtmanSchool of Life Sciences, University of Warwick , Coventry , United Kingdom.
Sean MeadenCollege of Life and Environmental Sciences, University of Exeter , United Kingdom.
Martha R J ClokieDepartment of Infection, Immunity and Inflammation, University of Leicester.
Britt KoskellaCollege of Life and Environmental Sciences, University of Exeter, United Kingdom; Department of Integrative Biology, University of California, Berkeley, California, United States.
Andrew D MillardWarwick Medical School, University of Warwick , United Kingdom.

Funding

Medical Research Council MR/L015080/1
6 · The paper itself

Abstract

Bacteriophages are the most abundant biological entities on the planet, playing crucial roles in the shaping of bacterial populations. Phages have smaller genomes than their bacterial hosts, yet there are currently fewer fully sequenced phage than bacterial genomes. We assessed the suitability of Illumina technology for high-throughput sequencing and subsequent assembly of phage genomes. In silico datasets reveal that 30× coverage is sufficient to correctly assemble the complete genome of ~98.5% of known phages, with experimental data confirming that the majority of phage genomes can be assembled at 30× coverage. Furthermore, in silico data demonstrate it is possible to co-sequence multiple phages from different hosts, without introducing assembly errors.

Indexed as

AssemblyBacteriophageGenomeIlluminaSequencing

Identifiers

PMID27280068
PMCPMC4893331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.